• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

对卵巢癌细胞具有抗癌活性的杂芳维甲酸类化合物。

Heteroarotinoids with anti-cancer activity against ovarian cancer cells.

作者信息

Le Thanh C, Berlin K Darrell, Benson Stacy D, Eastman Margaret A, Bell-Eunice Gianna, Nelson Anna C, Benbrook Doris M

机构信息

Department of Chemistry, Oklahoma State University, Stillwater, OK 74078, USA.

出版信息

Open Med Chem J. 2007 Oct 24;1:11-23. doi: 10.2174/1874104500701010011.

DOI:10.2174/1874104500701010011
PMID:19662136
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2709466/
Abstract

The Flex-Het compound 10a (SHetA2-NSC 721689) {[4-nitrophenylamino][(2,2,4,4-tetramethylthiochroman-6-yl)amino]methane-1-thione]} has shown promise in preclinical testing as an anti-cancer agent without evidence of toxicity, skin irritancy, or teratogenicity. One objective of this study was to synthesize a series of heteroarotinoids structurally related to SHetA2 and to measure the effect of structural alterations on the cytotoxicity activities of the compounds on A2780 ovarian cancer cells. Alterations included comparisons of activity of an NO2 end group versus a CO2Et end group, a thiourea linker versus a urea linker, and a distorted, thiochroman ring unit versus a planar quinoline ring unit. Cytotoxicity assays demonstrated the thiourea linker compounds to be similar in potency to the urea linker counterparts, the NO2 substitutions were slightly more potent than the CO2Et substitutions, and replacement of the thiochroman group with a planar quinoline fused ring system markedly reduced activity. The mechanism of cytotoxicity through apoptosis was confirmed for the compounds. The optimal combination of structural features for enhancing potency consisted of a urea linker, a NO2 substitution, and a flexible thiochroman unit. Extensive H-bonding in the more active urea derivative was confirmed by X-ray and NMR analyses. This is the first example in which the biological activity of flexible, thiochroman units is compared to that of fused aryl units in a heteroarotinoid molecule.

摘要

Flex-Het化合物10a(SHetA2-NSC 721689){[4-硝基苯氨基][(2,2,4,4-四甲基硫代苯并二氢吡喃-6-基)氨基]甲烷-1-硫酮}在临床前测试中显示出作为抗癌剂的潜力,且无毒性、皮肤刺激性或致畸性证据。本研究的一个目标是合成一系列与SHetA2结构相关的杂芳维甲酸,并测量结构改变对这些化合物对A2780卵巢癌细胞细胞毒性活性的影响。改变包括比较NO2端基与CO2Et端基的活性、硫脲连接基与脲连接基的活性,以及扭曲的硫代苯并二氢吡喃环单元与平面喹啉环单元的活性。细胞毒性试验表明,硫脲连接基化合物的效力与脲连接基对应物相似,NO2取代比CO2Et取代略强,用平面喹啉稠环系统取代硫代苯并二氢吡喃基团会显著降低活性。证实了这些化合物通过凋亡产生细胞毒性的机制。增强效力的结构特征的最佳组合包括脲连接基、NO2取代和柔性硫代苯并二氢吡喃单元。通过X射线和核磁共振分析证实了活性更高的脲衍生物中存在广泛的氢键。这是第一个在杂芳维甲酸分子中将柔性硫代苯并二氢吡喃单元的生物活性与稠合芳基单元的生物活性进行比较的例子。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1aa2/2709466/3c08557e0412/TOMCJ-1-11_F5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1aa2/2709466/cfc643aec885/TOMCJ-1-11_F1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1aa2/2709466/d2fd6da50494/TOMCJ-1-11_F2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1aa2/2709466/a89dfbbc455c/TOMCJ-1-11_F3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1aa2/2709466/f9e16cc9f78d/TOMCJ-1-11_F4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1aa2/2709466/3c08557e0412/TOMCJ-1-11_F5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1aa2/2709466/cfc643aec885/TOMCJ-1-11_F1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1aa2/2709466/d2fd6da50494/TOMCJ-1-11_F2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1aa2/2709466/a89dfbbc455c/TOMCJ-1-11_F3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1aa2/2709466/f9e16cc9f78d/TOMCJ-1-11_F4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1aa2/2709466/3c08557e0412/TOMCJ-1-11_F5.jpg

相似文献

1
Heteroarotinoids with anti-cancer activity against ovarian cancer cells.对卵巢癌细胞具有抗癌活性的杂芳维甲酸类化合物。
Open Med Chem J. 2007 Oct 24;1:11-23. doi: 10.2174/1874104500701010011.
2
Tetrahydroquinoline units in flexible heteroarotinoids (Flex-Hets) convey anti-cancer properties in A2780 ovarian cancer cells.柔性杂芳稠环酮(Flex-Hets)中的四氢喹啉单元在 A2780 卵巢癌细胞中具有抗癌特性。
Bioorg Med Chem. 2020 Jan 1;28(1):115244. doi: 10.1016/j.bmc.2019.115244. Epub 2019 Dec 2.
3
Synthesis and evaluation of second generation Flex-Het scaffolds against the human ovarian cancer A2780 cell line.第二代 Flex-Het 支架的合成与评估,针对人卵巢癌细胞系 A2780。
Eur J Med Chem. 2015;96:209-17. doi: 10.1016/j.ejmech.2015.03.070. Epub 2015 Apr 4.
4
Activity of oxygen-versus sulfur-containing analogs of the Flex-Het anticancer agent SHetA2.氧代-硫代类似物的活性,作为抗癌剂 SHetA2 的 Flex-Het。
Eur J Med Chem. 2018 Oct 5;158:720-732. doi: 10.1016/j.ejmech.2018.09.036. Epub 2018 Sep 14.
5
Synthesis and biological evaluation of SHetA2 (NSC-721689) analogs against the ovarian cancer cell line A2780.SHetA2(NSC-721689)类似物的合成及对卵巢癌细胞系 A2780 的生物评价。
Eur J Med Chem. 2019 May 15;170:16-27. doi: 10.1016/j.ejmech.2019.03.010. Epub 2019 Mar 7.
6
Flexible heteroarotinoids (Flex-Hets) exhibit improved therapeutic ratios as anti-cancer agents over retinoic acid receptor agonists.与维甲酸受体激动剂相比,柔性杂芳维甲酸类化合物(Flex-Hets)作为抗癌药物具有更高的治疗指数。
Invest New Drugs. 2005 Oct;23(5):417-28. doi: 10.1007/s10637-005-2901-5.
7
Novel heteroarotinoids: synthesis and biological activity.新型杂芳维甲酸类化合物:合成与生物活性
J Med Chem. 1991 Jan;34(1):430-9. doi: 10.1021/jm00105a065.
8
The synthetic heteroarotinoid SHetA2 induces apoptosis in squamous carcinoma cells through a receptor-independent and mitochondria-dependent pathway.合成杂环维甲酸SHetA2通过非受体依赖性和线粒体依赖性途径诱导鳞状癌细胞凋亡。
Cancer Res. 2003 Jul 1;63(13):3826-32.
9
Development of flexible-heteroarotinoids for kidney cancer.开发用于肾癌的柔性杂芳基替莫唑胺。
Mol Cancer Ther. 2009 May;8(5):1227-38. doi: 10.1158/1535-7163.MCT-08-1069. Epub 2009 May 5.
10
Synthesis of flexible sulfur-containing heteroarotinoids that induce apoptosis and reactive oxygen species with discrimination between malignant and benign cells.可诱导细胞凋亡和活性氧生成且能区分恶性细胞与良性细胞的柔性含硫杂阿罗他汀类化合物的合成。
J Med Chem. 2004 Feb 12;47(4):999-1007. doi: 10.1021/jm030346v.

引用本文的文献

1
Thiochromenes and thiochromanes: a comprehensive review of their diverse biological activities and structure-activity relationship (SAR) insights.硫代色烯和硫代色满:对其多样生物活性及构效关系(SAR)见解的全面综述
RSC Med Chem. 2025 Mar 24;16(5):1941-1968. doi: 10.1039/d4md00995a. eCollection 2025 May 22.
2
Biotransformation of Thiochroman Derivatives Using Marine-Derived Fungi: Isolation, Characterization, and Antimicrobial Activity.利用海洋来源真菌对硫代色满衍生物进行生物转化:分离、表征及抗菌活性
Int J Mol Sci. 2025 Jan 22;26(3):908. doi: 10.3390/ijms26030908.
3
Bioanalytical method development and validation of HPLCUV assay for the quantification of SHetA2 in mouse and human plasma: Application to pharmacokinetics study.

本文引用的文献

1
Flex-Hets differentially induce apoptosis in cancer over normal cells by directly targeting mitochondria.Flex-Hets通过直接靶向线粒体,在癌细胞中比正常细胞更易诱导凋亡。
Mol Cancer Ther. 2007 Jun;6(6):1814-22. doi: 10.1158/1535-7163.MCT-06-0279.
2
Crystal and molecular structure of n,n'-diethyl-n,n'-diphenylurea.N,N'-二乙基-N,N'-二苯基脲的晶体和分子结构
Proc Natl Acad Sci U S A. 1970 Sep;67(1):426-33. doi: 10.1073/pnas.67.1.426.
3
High performance liquid chromatographic analysis and preclinical pharmacokinetics of the heteroarotinoid antitumor agent, SHetA2.
用于定量小鼠和人血浆中SHetA2的HPLCUV分析法的生物分析方法开发与验证:在药代动力学研究中的应用。
J Pharm Technol Drug Res. 2017;6. doi: 10.7243/2050-120X-6-2.
4
Development of a dietary formulation of the SHetA2 chemoprevention drug for mice.为小鼠研发一种 SHetA2 化学预防药物的饮食配方。
Invest New Drugs. 2018 Aug;36(4):561-570. doi: 10.1007/s10637-017-0550-0. Epub 2017 Dec 22.
5
Chemoprevention of colon and small intestinal tumorigenesis in APC(min/+) mice by SHetA2 (NSC721689) without toxicity.SHetA2(NSC721689)在无毒性的情况下预防 APC(min/+) 小鼠的结肠和小肠肿瘤形成。
Cancer Prev Res (Phila). 2013 Sep;6(9):908-16. doi: 10.1158/1940-6207.CAPR-13-0171. Epub 2013 Jul 12.
6
Induction of death receptor ligand-mediated apoptosis in epithelial ovarian carcinoma: The search for sensitizing agents.诱导上皮性卵巢癌中死亡受体配体介导的细胞凋亡:寻找增敏剂。
Gynecol Oncol. 2009 Dec;115(3):438-42. doi: 10.1016/j.ygyno.2009.09.007. Epub 2009 Oct 4.
7
Development of flexible-heteroarotinoids for kidney cancer.开发用于肾癌的柔性杂芳基替莫唑胺。
Mol Cancer Ther. 2009 May;8(5):1227-38. doi: 10.1158/1535-7163.MCT-08-1069. Epub 2009 May 5.
杂环维甲酸类抗肿瘤药物SHetA2的高效液相色谱分析及临床前药代动力学
Cancer Chemother Pharmacol. 2006 Nov;58(5):561-9. doi: 10.1007/s00280-006-0211-z. Epub 2006 Mar 14.
4
Synthetic retinoids: recent developments concerning structure and clinical utility.合成维甲酸:关于结构与临床应用的最新进展
J Med Chem. 2005 Sep 22;48(19):5875-83. doi: 10.1021/jm0581821.
5
Novel potent antagonists of transient receptor potential channel, vanilloid subfamily member 1: structure-activity relationship of 1,3-diarylalkyl thioureas possessing new vanilloid equivalents.瞬时受体电位通道香草酸亚家族成员1的新型强效拮抗剂:具有新型香草酸类似物的1,3-二芳基烷基硫脲的构效关系
J Med Chem. 2005 Sep 8;48(18):5823-36. doi: 10.1021/jm0502790.
6
Flexible heteroarotinoids (Flex-Hets) exhibit improved therapeutic ratios as anti-cancer agents over retinoic acid receptor agonists.与维甲酸受体激动剂相比,柔性杂芳维甲酸类化合物(Flex-Hets)作为抗癌药物具有更高的治疗指数。
Invest New Drugs. 2005 Oct;23(5):417-28. doi: 10.1007/s10637-005-2901-5.
7
Unveiling the full potential of flexible receptor docking using multiple crystallographic structures.利用多个晶体学结构揭示柔性受体对接的全部潜力。
J Med Chem. 2005 Jun 30;48(13):4432-43. doi: 10.1021/jm048972v.
8
Synthesis and evaluation of new antimalarial phenylurenyl chalcone derivatives.新型抗疟苯基脲基查尔酮衍生物的合成与评价
J Med Chem. 2005 May 19;48(10):3654-8. doi: 10.1021/jm058208o.
9
Antagonist analogue of 6-[3'-(1-adamantyl)-4'-hydroxyphenyl]-2-naphthalenecarboxylic acid (AHPN) family of apoptosis inducers that effectively blocks AHPN-induced apoptosis but not cell-cycle arrest.6-[3'-(1-金刚烷基)-4'-羟基苯基]-2-萘甲酸(AHPN)凋亡诱导剂家族的拮抗剂类似物,其可有效阻断AHPN诱导的细胞凋亡,但不阻断细胞周期停滞。
J Med Chem. 2004 Jul 1;47(14):3518-36. doi: 10.1021/jm030524k.
10
Molecular mechanism of chemoresistance to cisplatin in ovarian cancer cell lines.卵巢癌细胞系对顺铂耐药的分子机制
Int J Mol Med. 2004 Jun;13(6):865-8.